Synthetic Biology

Synthetic biology is an emerging multidisciplinary science encompassing biology, chemistry, engineering and computation. It has a broad ranging application and will impact numerous industries, especially those relating to bioprocessing, such as in the design and construction of new biological parts, devices, and systems, and the re-design of existing, natural biological systems for useful purposes.

New metabolic routes to biofuels, renewable chemicals and pharmaceuticals may be designed by this exciting new area of science. This is made possible by creating new microbial strains, in a rational design approach, that harbour sets of genes and enzymes not normally found within the organism. The result is an organism that will perform brand new tasks or one that performs existing task in a more efficient way.

Synthetic biology has been highlighted by the Technology Strategy Board (TSB) as a priority target for investment, with the potential to create a £1B-plus industry within the next decade. Celbius has been awarded a grant worth up to £0.25M from the TSB and is actively engaged in synthetic biology projects as part of its strategic scientific direction, including working with the University of Northumbria. This will give the company access to novel technology and microbial strains that produce some key products from low cost raw materials.

The application and commercialization of synthetic biology will underpin the company’s broader technology development in Sonobioprocessing. Celbius will create best-in-class bioprocesses- novel proprietary strains developed through synthetic biology that will be utilised in fermentation processes that are enhanced and intensified by sonication, including the use of ultrasound. 

Copyright Celbius Ltd 2015. Site designed by Dave Bate. Contact us via This email address is being protected from spambots. You need JavaScript enabled to view it.